Phreesia, Inc. Stock

Equities

PHR

US71944F1066

Software

Delayed Nyse 03:57:45 2024-05-09 pm EDT 5-day change 1st Jan Change
22.01 USD +0.32% Intraday chart for Phreesia, Inc. -1.21% -5.01%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Sales 2025 * 428M Sales 2026 * 507M Capitalization 1.24B
Net income 2025 * -92M Net income 2026 * -69M EV / Sales 2025 * 2.74 x
Net cash position 2025 * 65.84M Net cash position 2026 * 80.06M EV / Sales 2026 * 2.28 x
P/E ratio 2025 *
-13.2 x
P/E ratio 2026 *
-17.4 x
Employees 1,438
Yield 2025 *
-
Yield 2026 *
-
Free-Float 93%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.92%
1 week+4.43%
Current month+5.79%
1 month-4.15%
3 months-18.80%
6 months+40.19%
Current year-5.23%
More quotes
1 week
21.59
Extreme 21.59
23.18
1 month
20.20
Extreme 20.2
23.88
Current year
20.20
Extreme 20.2
29.16
1 year
12.05
Extreme 12.05
34.98
3 years
12.05
Extreme 12.05
76.10
5 years
12.05
Extreme 12.05
81.59
10 years
12.05
Extreme 12.05
81.59
More quotes
Managers TitleAgeSince
Founder 45 04-12-31
Founder 45 04-12-31
Director of Finance/CFO 50 19-06-30
Members of the board TitleAgeSince
Director/Board Member 71 07-09-30
Director/Board Member 53 19-04-30
Director/Board Member 56 20-07-19
More insiders
Date Price Change Volume
24-05-09 22.01 +0.32% 220 006
24-05-08 21.94 -2.92% 266,222
24-05-07 22.6 -0.35% 343,049
24-05-06 22.68 +1.61% 323,517
24-05-03 22.32 +0.27% 526,218

Delayed Quote Nyse, May 08, 2024 at 04:00 pm EDT

More quotes
Phreesia, Inc. is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations. The Company's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. The Company also provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The Company's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
21.94 USD
Average target price
30.12 USD
Spread / Average Target
+37.31%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW